Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breath-Based yoga may boost breastfeeding success in new moms

NCT ID NCT07435363

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding breath-based yoga to online breastfeeding education helps first-time mothers feel less anxious, more confident in breastfeeding, and less worried about not having enough milk. About 90 new mothers will take part, with some getting education plus yoga, some only education, and some standard care. The goal is to find simple ways to support breastfeeding and improve well-being after childbirth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Inclusion Criteria for Intervention and Control Groups * Primiparous mothers aged 19 years or older who delivered at term (37-42 weeks), * Mothers who gave birth in a Baby-Friendly Hospital in Sakarya, * Mothers who are open to communication and cooperation, voluntarily agree to participate in the study, and had a normal vaginal delivery, * Mothers who agree to participate in the study during postpartum weeks 0-2 and who will be in postpartum weeks 2-10 during the intervention period, * Mothers who breastfeed or practice mixed feeding, * Mothers and infants who are in good health, * Mothers with a Body Mass Index within the normal range, * Mothers without sensory impairments such as hearing or vision problems, * Mothers without a diagnosed psychiatric history, * Mothers who can read and write in Turkish, * Mothers who score below 13 on the Edinburgh Postpartum Depression Scale (EPDS) at the first assessment. Exclusion Criteria for Intervention and Control Groups * Infant loss, * Mothers with visual, auditory, or cognitive impairments, * Infants with physical disabilities or congenital anomalies, * Mothers with any neurological, orthopedic, or chronic condition that may prevent participation in exercise, * Mothers scoring 13 or above on the Edinburgh Postnatal Depression Scale (EPDS) at the first assessment, * Mothers who practiced yoga or breathing exercises during pregnancy or postpartum will be excluded, * Since brief educational sessions provided before discharge in Baby-Friendly Hospitals are routine in Turkey, they will not be considered exclusion criteria. * However, mothers who received a structured breastfeeding education program during pregnancy or postpartum will be excluded from the study. Withdrawal Criteria for Intervention and Control Groups * Participants who request to withdraw from the study at any time, * Participants who miss more than two yoga-breathing sessions, more than two breastfeeding education sessions, or who cannot be reached will be removed from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breastfeeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.